Cancer vaccines are closer than we thought!
The UK government has announced a partnership with the German firm ‘BioNTech’ to start testing potential cancer vaccines! This major news spreads hope to many people around the world. The vaccines are to be tested for cancer as well as other diseases!
We today announced signing an MoU with the UK government to accelerate trials for personalized #mRNA #immunotherapies. Our objective: providing personalized cancer therapies for up to 10k patients by end 2030 in clinical trials or as authorized treatments. https://t.co/bOWTuR7ty2 pic.twitter.com/A5e29bHk4p
— BioNTech SE (@BioNTech_Group) January 6, 2023
Amazing news! Additionally, campaigners added that any breakthrough has to be affordable and accessible to help as many people around the world as possible!
Cancer patients in the UK will get early access to trials set to involve personalized mRNA therapies. mRNA treatments are tailor-made for the individual and provide immune systems with the genetic code from specific cancer so it can attack only the tumor.
The administration will prioritize early and late-stage cancer patients. Also, it’ll target active cancer cells and prevent their return. BioNTech aims to deliver around 10,000 therapies to patients, starting September 2023 and until the end of the decade!
Major breakthrough!
READ MORE:
We Asked You What Your Fave Spot for Fried Chicken in Bahrain Was and Here Are the Top 10
READ MORE:
Cinema On, Lights Off! Here Are 14 Movies You Should Look Out for This January
READ MORE:
Here’s Why You Should Visit Wagalag This Season for the Best Time!
